YS Biopharma Co Ltd
NASDAQ:LSB

Watchlist Manager
YS Biopharma Co Ltd Logo
YS Biopharma Co Ltd
NASDAQ:LSB
Watchlist
Price: 3.08 USD -8.06% Market Closed
Market Cap: 58.8m USD
Have any thoughts about
YS Biopharma Co Ltd?
Write Note

YS Biopharma Co Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

YS Biopharma Co Ltd
Cost of Revenue Peer Comparison

Comparables:
6160
1801
603392
300122
300896

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
YS Biopharma Co Ltd
NASDAQ:LSB
Cost of Revenue
-ÂĄ117.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cost of Revenue
-ÂĄ2.7B
CAGR 3-Years
-77%
CAGR 5-Years
-70%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Cost of Revenue
-ÂĄ1.3B
CAGR 3-Years
-46%
CAGR 5-Years
-100%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cost of Revenue
-ÂĄ992.7m
CAGR 3-Years
-28%
CAGR 5-Years
-29%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cost of Revenue
-ÂĄ35.1B
CAGR 3-Years
-49%
CAGR 5-Years
-51%
CAGR 10-Years
-62%
Imeik Technology Development Co Ltd
SZSE:300896
Cost of Revenue
-ÂĄ140.8m
CAGR 3-Years
-36%
CAGR 5-Years
-32%
CAGR 10-Years
N/A

See Also

What is YS Biopharma Co Ltd's Cost of Revenue?
Cost of Revenue
-117.7m CNY

Based on the financial report for Mar 31, 2024, YS Biopharma Co Ltd's Cost of Revenue amounts to -117.7m CNY.

What is YS Biopharma Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 1Y
23%

Over the last year, the Cost of Revenue growth was 23%.

Back to Top